A RANDOMIZED PHASE IIB STUDY OF WEEKLY PACLITAXEL (PCT) ± TRASTUZUMAB (T) AS FIRST-LINE THERAPY OF PATIENTS (PTS) WITH HER–2/NEU POSITIVE METASTATIC BREAST CANCER (MBC): RESULTS OF THE FIRST INTERIM ANALYSIS


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles